"Medisinstart" is a new service developed for use in Norwegian pharmacies. It is intended for patients that are about to start a new medicine for a chronic or long-term condition. It is based on research showing that problems with newly prescribed medicines appear rapidly and that a significant portion of patients quickly becomes non-adherent. The service consists of two follow-up consultations with a pharmacist. The first at 1-2 weeks and the second at 3-5 weeks after start of the new medicine. The main purpose of this study is to investigate whether "Medisinstart" increases patients' adherence to the prescribed medication. Patients' beliefs about their medicines and their motivation for adherence will also be examined. The study also aims at revealing if "Medisinstart" has additional benefits for the patient, the society and the pharmacies.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
1,480
"Medisinstart" is a newly developed pharmacy service for patients about to start a new medicine for a chronic or long-term condition. It consists of two follow-up consultations with a pharmacist. The first at 1-2 weeks and the second at 3-5 weeks after start of the new medicine.
Apotek 1 Alta
Alta, Norway
Apotek 1 Andselv
Andselv, Norway
Boots apotek Harebakken
Arendal, Norway
Sykehusapoteket Arendal
Arendal, Norway
Boots apotek Moa
Ålesund, Norway
Vitusapotek Raumnes
Årnes, Norway
Adherence by Morisky 8-item Medication Adherence Scale (MMAS-8) at 7 weeks
Adherence will be measured by a validated Norwegian translation of the MMAS-8
Time frame: 7 weeks after dispensing the new medicine
Adherence by Morisky 8-item Medication Adherence Scale (MMAS-8) at 18 weeks
Adherence will be measured by a validated Norwegian translation of the MMAS-8
Time frame: 18 weeks after dispensing the new medicine
Self reported adherence at 7 weeks
Adherence will be measured by a Norwegian translation of the question: "People often miss taking doses of their medicines, for a wide range of reasons. Have you missed any doses of your new medicine the last week?"
Time frame: 7 weeks after dispensing the new medicine
Adherence by Medication Possession Ratio (MPR) at 18 weeks
Adherence by MPR will be calculated from data collected from the Norwegian Prescription Database
Time frame: 18 weeks after dispensing the new medicine
Patients' beliefs about their medicines by Beliefs about Medicines Questionnaire (BMQ) at inclusion
Patients' beliefs about their medicines will be measured by a validated Norwegian translation of the BMQ
Time frame: At inclusion
Self reported adherence at 18 weeks
Adherence will be measured by a Norwegian translation of the question: "People often miss taking doses of their medicines, for a wide range of reasons. Have you missed any doses of your new medicine the last week?"
Time frame: 18 weeks after dispensing the new medicine
Adherence by Medication Possession Ratio (MPR) at 1 year
Adherence by MPR will be calculated from data collected from the Norwegian Prescription Database
Time frame: 1 year after dispensing the new medicine
Patients' beliefs about their medicines by Beliefs about Medicines Questionnaire (BMQ) at 7 weeks
Patients' beliefs about their medicines will be measured by a validated Norwegian translation of the BMQ
Time frame: 7 weeks after dispensing the new medicine
Patients' beliefs about their medicines by Beliefs about Medicines Questionnaire (BMQ) at 18 weeks
Patients' beliefs about their medicines will be measured by a validated Norwegian translation of the BMQ
Time frame: 18 weeks after dispensing the new medicine
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Vitusapotek Årnes
Årnes, Norway
Apotek 1 Horisont
Bergen, Norway
Boots apotek Bryggen
Bergen, Norway
Sjukehusapoteket i Bergen
Bergen, Norway
...and 57 more locations